← Leaderboards
Steffan T Nawrocki
University Of Texas Hlth Science Center
$3,168,835
Attributed
$4,285,899
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $739.2K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,285,899 · 5
By mechanism
R01$3,457,707 · 2
R21$325,162 · 1
R41$258,341 · 1
P30$244,689 · 1
Top collaborators
- Jennifer S Carew5 shared
- Wei Wang1 shared
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Gregory Talisker Macleod$6,488,617
- Gangadhara R Sareddy$1,601,264
- Ganesh V Raj$2,616,233
- Mengwei Zang$6,036,590
- Pei Wang$4,519,046
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAutophagocytosisOrganellesPathogenesisStressDrug ResistanceProteinsBaseExhibitsMouse ModelCancer TherapySourceClinically RelevantInhibitorCancer CellOverexpressionProtein BiosynthesisLinkApoptosisHypersensitivityApoptoticEndoplasmic Reticulum StressClinical TrialsMediating
Grant awards (16)
Targeting Lysosomal Vulnerabilities in Renal Pathogenesis$480,833
R01 · FY2025 · CA · contact PI
Clinical and Translational Oncology Program (CTOP)$85,677
P30 · FY2025 · CA · contact PI
Targeting Lysosomal Vulnerabilities in Renal Pathogenesis$456,791
R01 · FY2024 · CA · contact PI
Clinical and Translational Oncology Program (CTOP)$79,506
P30 · FY2024 · CA · contact PI
Targeting Lysosomal Vulnerabilities in Renal Pathogenesis$471,216
R01 · FY2023 · CA · contact PI
Clinical and Translational Oncology Program (CTOP)$79,506
P30 · FY2023 · CA · contact PI
Targeting Lysosomal Vulnerabilities in Renal Pathogenesis$480,833
R01 · FY2022 · CA · contact PI
Development of lysosome targeted therapeutics$258,341
R41 · FY2022 · CA
Endoplasmic reticulum stress and oncoviral therapy$316,018
R01 · FY2020 · CA · contact PI
Endoplasmic reticulum stress and oncoviral therapy$306,536
R01 · FY2019 · CA · contact PI
Endoplasmic reticulum stress and oncoviral therapy$316,018
R01 · FY2018 · CA · contact PI
Endoplasmic reticulum stress and oncoviral therapy$316,018
R01 · FY2017 · CA · contact PI
Endoplasmic reticulum stress and oncoviral therapy$276,675
R01 · FY2015 · CA · contact PI
Disrupting Brain Metastogenesis in Breast Cancer$162,581
R21 · FY2015 · CA · contact PI
Endoplasmic reticulum stress and oncoviral therapy$36,769
R01 · FY2015 · CA · contact PI
Disrupting Brain Metastogenesis in Breast Cancer$162,581
R21 · FY2014 · CA · contact PI